The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Prospective Study of the Clinical Course, Prognostic Factors, Causes of Death, and Survival in Patients With Long-Standing Zollinger-Ellison Syndrome
Abstract
PURPOSE: The long-term clinical course of unselected patients with gastrinomas as well as other functional pancreatic endocrine tumors (PETs) in whom the excess-hormone state is controlled is largely unknown. To address this issue, patients with gastrinomas were assessed. PATIENTS AND METHODS: Two hundred twelve patients with Zollinger-Ellison syndrome (ZES) were prospectively studied. All had controlled acid hypersecretion and were assessed yearly, with a mean follow-up period of 13.8 ± 0.6 years (range, 0.1 to 31 years). Annual assessments of possible factors that might affect prognosis or treatment approaches were performed, such as those for tumor size and location; the presence, location, and extent of metastases; and the occurrence of ectopic Cushing's syndrome or another PET syndrome. Deaths were categorized as ZES-related or non–ZES-related and classified into different causes. RESULTS: Thirty-one percent of patients died, all of non–acid-related causes. One half died of a ZES-related cause; they differed from those who died of non–ZES deaths by having a large primary tumor, more frequently a pancreatic tumor; lymph node, liver, or bone metastases; ectopic Cushing's syndrome; or higher gastrin levels. The extent of liver metastases correlated with survival rate. The presence of liver metastases alone only moderately decreased survival time; however, the additional development of bone metastases or ectopic Cushing's syndrome markedly decreased survival rate. CONCLUSIONS: In ZES, gastrinoma growth is now the main single determinant of long-term survival, with one half of patients dying a gastrinoma-related death and none an acid-related death. Large primary tumors that are pancreatic in location, the development of liver metastases, (especially if associated with bone metastases or Cushing's syndrome), and the extent of liver metastases are all important prognostic factors. The identification of these factors allows the recognition of subgroups that can be used to tailor antitumor treatment approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Applying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975
Moertel, C. G., Hanley, J. A., & Johnson, L. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032101 · Cited by 659
The Pancreas : biology, pathobiology, and disease
Go, V. L. W. (1993) · Raven Press eBooks · Cited by 526
Karnofsky memorial lecture. An odyssey in the land of small tumors.
Moertel, C. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1502 · Cited by 473
Weber, H. C., Venzon, D. J., Lin, J.-T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., Norton, J. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90124-8 · Cited by 467
Self-citationThe Zollinger-Ellison Syndrome: Re-appraisal and Evaluation of 260 Registered Cases
ELLISON, E. H., & WILSON, S. D. (1964) · Annals of Surgery · doi:10.1097/00000658-196409000-00013 · Cited by 444
Gibril, F., Reynolds, J. C., Doppman, J. L., Chen, C. C., Venzon, D. J., Termanini, B., Weber, H. C., Stewart, C. A., & Jensen, R. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00005 · Cited by 440
Self-citationCytoreductive hepatic surgery for neuroendocrine tumors.
Gp, M., Nagorney, D. M., Lk, K., Cg, M., & Cs, G. (1990) · PubMed · Cited by 381
Arnold, R., Trautmann, M. E., Creutzfeldt, W., Benning, R., Benning, M., Neuhaus, C., Jürgensen, R., Stein, K., Schäfer, H., Bruns, C., et al. (1996) · Gut · doi:10.1136/gut.38.3.430 · Cited by 342
The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas
Moertel, C. G., Johnson, C. M., McKusick, M. A., Martin, J. K., Nagorney, D. M., Kvols, L. K., Rubin, J., & Kunselman, S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00008 · Cited by 292
Estimation of confidence limits for the cumulative probability of survival in life table analysis
Rothman, K. J. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90043-7 · Cited by 282
Treut, Y. P. L., Delpéro, J., Dousset, B. E., Cherqui, D., Segol, P., Mantion, G., Hannoun, L., Benhamou, G., Launois, B., Boillot, O., et al. (1997) · Annals of Surgery · doi:10.1097/00000658-199704000-00003 · Cited by 276
Curative Resection in Zollinger-Ellison Syndrome Results of a 10-Year Prospective Study
NORTON, J. A., DOPPMAN, J. L., & JENSEN, R. T. (1992) · Annals of Surgery · doi:10.1097/00000658-199201000-00012 · Cited by 218
Self-citationTermanini, B., Gibril, F., Reynolds, J., Doppman, J., Chen, C., Stewart, C., Sutliff, V., & Jensen, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024287 · Cited by 206
Self-citationSecretin and Calcium Provocative Tests in the Zollinger-Ellison Syndrome: A Prospective Study
Frucht, H., Howard, J. M., Slaff, J. I., Wank, S. A., McCarthy, D. M., Maton, P. N., Vinayek, R., Gardner, J. D., & Jensen, R. T. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-9-713 · Cited by 184
Self-citationDonow, C., Pipeleers-Marichal, M., Schröder, S., Stamm, B., Heitz, P. U., & Klöppel, G. (1991) · Cancer · doi:10.1002/1097-0142(19910915)68:6<1329::aid-cncr2820680624>3.0.co;2-7 · Cited by 181
Treatment of Metastatic Islet Cell Carcinoma with a Somatostatin Analogue (SMS 201-995)
KVOLS, L. K., BUCK, M., MOERTEL, C. G., SCHUTT, A. J., RUBIN, J., O'CONNELL, M. J., & HAHN, R. G. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-162 · Cited by 168
Cushing's Syndrome in Patients with the Zollinger–Ellison Syndrome
Maton, P. N., Gardner, J. D., & Jensen, R. T. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607033150101 · Cited by 168
Self-citationAggressive Resection of Metastatic Disease in Selected Patients with Malignant Gastrinoma
Norton, J. A., Sugarbaker, P. H., Doppman, J. L., WESLEY, R. A., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1986) · Annals of Surgery · doi:10.1097/00000658-198604000-00003 · Cited by 155
Self-citationA Prospective Study of Intraoperative Methods to Diagnose and Resect Duodenal Gastrinomas
Sugg, S. L., Norton, J. A., Fraker, D. L., Metz, D. C., Pisegna, J. R., Fishbeyn, V. A., Benya, R. V., Shawker, T. H., Doppman, J. L., & Jensen, R. T. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00004 · Cited by 155
Self-citationEctopic adrenocorticotropic hormone syndrome: localization studies in 28 patients.
Doppman, J. L., Nieman, L. K., Miller, D. L., Pass, H. I., Chang, R., Cutler, G. B., Schaaf, M., Chrousos, G. P., Norton, J. A., & Ziessman, H. A. (1989) · Radiology · doi:10.1148/radiology.172.1.2544919 · Cited by 151
Self-citationMedical and surgical options in the management of patients with gastrinoma
Malagelada, J., Edis, A. J., Adson, M. A., van Heerden, J. A., & Go, V. L. W. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90375-x · Cited by 146
Gibril, F., Doppman, J. L., Reynolds, J. C., Chen, C. C., Sutliff, V. E., Yu, F., Serrano, J., Venzon, D. J., & Jensen, R. T. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1040 · Cited by 142
Self-citationNeuroendocrine tumors of the pancreas and duodenum
Norton, J. A. (1994) · Current Problems in Surgery · doi:10.1016/0011-3840(94)90079-5 · Cited by 135
Fishbeyn, V. A., Norton, J. A., Benya, R. V., Pisegna, J. R., Venzon, D. J., Metz, D. C., & Jensen, R. T. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-3-199308010-00004 · Cited by 135
Self-citationNeuroendocrine Pancreatic Tumors Clinical Findings in a prospective study of 84 patients
Eriksson, B. K., Ouberg, K., & Skogseid, B. M. (1989) · Acta Oncologica · doi:10.3109/02841868909111209 · Cited by 128
Benya, R. V., Metz, D. C., Venzon, D. J., Fishbeyn, V. A., Strader, D. B., Orbuch, M., & Jensen, R. T. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90323-9 · Cited by 126
Self-citationDetection of duodenal gastrinomas by operative endoscopic transillumination
Frucht, H., Norton, J. A., London, J. F., Vinayek, R., Doppman, J. L., Gardner, J. D., Jensen, R. T., & Maton, P. N. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90466-e · Cited by 125
Self-citationResults of Surgical Management in 92 Consecutive Patients with Zollinger-Ellison Syndrome
Bonfils, S., Landor, J. H., Mignon, M., & HERVOIR, P. (1981) · Annals of Surgery · doi:10.1097/00000658-198112000-00005 · Cited by 121
Surgical Management of the Zollinger-Ellison Syndrome
Fox, P. S., Hofmann, J. W., Wilson, S. D., & DeCosse, J. J. (1974) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)40287-2 · Cited by 112
Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns.
Sutliff, V. E., Doppman, J. L., Gibril, F., Venzon, D. J., Yu, F., Serrano, J., & Jensen, R. T. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2420 · Cited by 108
Self-citationProgression of Metastases and Symptom Improvement from Laparotomy in Midgut Carcinoid Tumors
Makridis, C., Rastad, J., Öberg, K., & Åkerström, G. (1996) · World Journal of Surgery · doi:10.1007/s002689900137 · Cited by 97
Current approach to the management of tumoral process in patients with gastrinoma
Mignon, M., Ruszniewski, P. B., Haffar, S., Rigaud, D., René, E., & Bonfils, S. (1986) · World Journal of Surgery · doi:10.1007/bf01655562 · Cited by 93
Thirty years' experience with gastrinoma
Zollinger, R. M., Ellison, E. C., O’Dorisio, T. M., & Sparks, J. (1984) · World Journal of Surgery · doi:10.1007/bf01654904 · Cited by 92
Control of gastric acid hypersecretion in the management of patients with Zollinger‐Ellison syndrome
Metz, D. C., Pisegna, J. R., Fishbeyn, V. A., Benya, R. V., & Jensen, R. T. (1993) · World Journal of Surgery · doi:10.1007/bf01655106 · Cited by 91
Self-citationRuszniewski, P. B., Podevin, P., Cadiot, G., Marmuse, J., Mignon, M., Vissuzaine, C., Bonfils, S., & Lehy, T. (1993) · Pancreas · doi:10.1097/00006676-199305000-00003 · Cited by 89
Multiple Endocrine Neoplasia, Type I (MEN I)
Eberle, F. C., & Grün, R. (1981) · Ergebnisse der inneren Medizin und Kinderheilkunde · doi:10.1007/978-3-642-67954-4_3 · Cited by 83
Pisegna, J. R., Doppman, J. L., Norton, J. A., Metz, D. C., & Jensen, R. T. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01296084 · Cited by 78
Self-citationNatural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome.
Jc, T., Reeder, D. D., Villar, H. V., & Hr, F. (1975) · PubMed · Cited by 76
Avgerinos, P. C., Yanovski, J. A., Oldfield, E. H., Nieman, L. K., & Cutler, G. B. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-5-199409010-00002 · Cited by 70
The Use of Chemotherapy in the Management of Neuroendocrine Tumors
Öberg, K. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30142-7 · Cited by 67
Gastrinoma: factors influencing prognosis.
Rm, Z. (1985) · PubMed · Cited by 61
Early surgical treatment of gastrinoma
Ellison, E. C., Carey, L. C., Sparks, J., O’Dorisio, T. M., Mekhjian, H. S., Fromkes, J. J., Caldwell, J. H., & Thomas, F. B. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90423-2 · Cited by 56
Jensen, R. T. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90016-0 · Cited by 44
Self-citationGastrointestinal endocrine tumours: Medical management
Arnold, R., & Frank, M. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90021-4 · Cited by 30
Jensen, R. T. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-6355-6_14 · Cited by 19
Self-citationBozymski, E. M., Woodruff, K., & Sessions, J. T. (1973) · Gastroenterology · doi:10.1016/s0016-5085(19)33049-5 · Cited by 19
Bishop, A. E., & Polak, J. M. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90013-5 · Cited by 11
A note on linear rank tests and Gill and Schumacher's tests of proportionality
Chappell, R. J. (1992) · Biometrika · doi:10.1093/biomet/79.1.199 · Cited by 10
Cited by
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Self-citationThe diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Self-citationKouvaraki, M. A., Ajani, J. A., Hoff, P., Wolff, R., Evans, D. B., Lozano, R., & Yao, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.024 · Cited by 607
Metadata
- Authors
- Yu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., & Jensen, R. T.
- Venue
- Journal of Clinical Oncology
- Published
- 1999-02
- Volume
- 17
- Issue
- 2
- Pages
- 615-615
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1917620582
- Cited by
- 341
- References
- 53
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.